According to Arrowhead Pharmaceuticals
's latest financial reports the company has A$0.87 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-09-30 | A$0.98 B | 56.74% |
2023-09-30 | A$0.62 B | 8.65% |
2022-09-30 | A$0.57 B | 12.82% |
2021-09-30 | A$0.51 B | 15.99% |
2020-09-30 | A$0.44 B | 15.42% |
2019-09-30 | A$0.38 B | 261.2% |
2018-09-30 | A$0.10 B | 26.57% |
2017-09-30 | A$83.69 M | -25.21% |
2016-09-30 | A$0.11 B | -20.63% |
2015-09-30 | A$0.14 B | -20.27% |
2014-09-30 | A$0.17 B | 484.49% |
2013-09-30 | A$30.25 M | 801.38% |
2012-09-30 | A$3.35 M | -59.74% |
2011-09-30 | A$8.33 M | 18.05% |
2010-09-30 | A$7.06 M | 209.01% |
2009-09-30 | A$2.28 M | -82.05% |
2008-09-30 | A$12.73 M | -53.62% |
2007-09-30 | A$27.45 M | -26.9% |
2006-09-30 | A$37.56 M | 26.53% |
2005-09-30 | A$29.68 M | 135.38% |
2004-09-30 | A$12.61 M | 531.46% |
2003-09-30 | A$1.99 M | 5771.88% |
2002-09-30 | A$0.03 M | 6073.1% |
2001-09-30 | A$0 M | -84.63% |
2000-09-30 | A$0 M | 1788.89% |
1999-09-30 | A$0 M | -88.94% |
1998-09-30 | A$0 M | 6.83% |
1997-09-30 | A$0 M |